Cadila Healthcare hit a new high today at Rs.453 and continues to remain firmly in the green at Rs.450 levels, up 6.5% currently.
The stock price has reacted positively to the news that it might be able to launch the Covid vaccine by March 2021.
Zydus Cadila said that it will apply for Phase 3 clinical trials of its vaccine in December and expects to launch it by March 2021. The company will be submitting the results of the Phase 2 trial next week.
The Phase 3 trial will enroll 39,000 participants.
Those in the know say that its vaccine, ZyCoV-D, has got no safety concerns and is a promising vaccine.